UCL researchers found that suppressive immune cells build up months or years before lung cancer forms, tracked them with prototype blood tests and halved tumor formation in mice with a drug.
Stanford researchers' urine test, uRARE-seq, detected localized bladder cancer with 95% sensitivity at 90% specificity in 683 samples and flagged which patients were more likely to respond to BCG immunotherapy.
University of Hawaiʻi researchers found 31 small RNA molecules in stored blood samples that were linked to lung cancer up to a decade before diagnosis. The study covered 202 smokers and still needs testing in other groups.